Literature DB >> 29317545

Interstitial lung abnormalities and self-reported health and functional status.

Gisli Thor Axelsson1,2, Rachel K Putman3, Tetsuro Araki4,5, Sigurdur Sigurdsson1, Elias Freyr Gudmundsson1, Gudny Eiriksdottir1, Thor Aspelund1,2, Ezra R Miller3, Lenore J Launer6, Tamara B Harris6, Hiroto Hatabu4,5, Vilmundur Gudnason1,2, Gary Matt Hunninghake3,5, Gunnar Gudmundsson2,7.   

Abstract

We investigated the association between interstitial lung abnormalities (ILA) and self-reported measures of health and functional status in 5764 participants from the Age, Gene/Environment Susceptibility-Reykjavik study. The associations of ILA to activities of daily living (ADLs), general health status and physical activity were explored using logistic regression models. Participants with ILA were less likely to be independent in ADLs (OR 0.70; 95% CI 0.55 to 0.90) to have good or better self-reported health (OR 0.66; 95% CI 0.52 to 0.82) and to participate in physical activity (OR 0.72; CI 0.56 to 0.91). The results demonstrate ILA's association with worsening self-reported health and functional status. © Article author(s) (or their employer(s) unless otherwise stated in the text of the article) 2018. All rights reserved. No commercial use is permitted unless otherwise expressly granted.

Entities:  

Keywords:  idiopathic pulmonary fibrosis; imaging/ct mri etc; interstitial fibrosis

Mesh:

Year:  2018        PMID: 29317545      PMCID: PMC6037567          DOI: 10.1136/thoraxjnl-2017-210956

Source DB:  PubMed          Journal:  Thorax        ISSN: 0040-6376            Impact factor:   9.139


  9 in total

Review 1.  American Thoracic Society/European Respiratory Society International Multidisciplinary Consensus Classification of the Idiopathic Interstitial Pneumonias. This joint statement of the American Thoracic Society (ATS), and the European Respiratory Society (ERS) was adopted by the ATS board of directors, June 2001 and by the ERS Executive Committee, June 2001.

Authors: 
Journal:  Am J Respir Crit Care Med       Date:  2002-01-15       Impact factor: 21.405

2.  Effect of vertebral fractures on function, quality of life and hospitalisation the AGES-Reykjavik study.

Authors:  Kristin Siggeirsdottir; Thor Aspelund; Brynjolfur Y Jonsson; Brynjolfur Mogensen; Lenore J Launer; Tamara B Harris; Gunnar Sigurdsson; Vilmundur Gudnason
Journal:  Age Ageing       Date:  2012-02-23       Impact factor: 10.668

Review 3.  Subclinical interstitial lung disease: why you should care.

Authors:  Tracy J Doyle; Gary M Hunninghake; Ivan O Rosas
Journal:  Am J Respir Crit Care Med       Date:  2012-02-23       Impact factor: 21.405

4.  Interstitial lung abnormalities and reduced exercise capacity.

Authors:  Tracy J Doyle; George R Washko; Isis E Fernandez; Mizuki Nishino; Yuka Okajima; Tsuneo Yamashiro; Miguel J Divo; Bartolome R Celli; Frank C Sciurba; Edwin K Silverman; Hiroto Hatabu; Ivan O Rosas; Gary M Hunninghake
Journal:  Am J Respir Crit Care Med       Date:  2012-01-20       Impact factor: 21.405

5.  High attenuation areas on chest computed tomography in community-dwelling adults: the MESA study.

Authors:  Anna J Podolanczuk; Elizabeth C Oelsner; R Graham Barr; Eric A Hoffman; Hilary F Armstrong; John H M Austin; Robert C Basner; Matthew N Bartels; Jason D Christie; Paul L Enright; Bernadette R Gochuico; Karen Hinckley Stukovsky; Joel D Kaufman; P Hrudaya Nath; John D Newell; Scott M Palmer; Dan Rabinowitz; Ganesh Raghu; Jessica L Sell; Jered Sieren; Sushil K Sonavane; Russell P Tracy; Jubal R Watts; Kayleen Williams; Steven M Kawut; David J Lederer
Journal:  Eur Respir J       Date:  2016-07-28       Impact factor: 16.671

6.  Age, Gene/Environment Susceptibility-Reykjavik Study: multidisciplinary applied phenomics.

Authors:  Tamara B Harris; Lenore J Launer; Gudny Eiriksdottir; Olafur Kjartansson; Palmi V Jonsson; Gunnar Sigurdsson; Gudmundur Thorgeirsson; Thor Aspelund; Melissa E Garcia; Mary Frances Cotch; Howard J Hoffman; Vilmundur Gudnason
Journal:  Am J Epidemiol       Date:  2007-03-10       Impact factor: 4.897

7.  MUC5B promoter polymorphism and interstitial lung abnormalities.

Authors:  Gary M Hunninghake; Hiroto Hatabu; Yuka Okajima; Wei Gao; Josée Dupuis; Jeanne C Latourelle; Mizuki Nishino; Tetsuro Araki; Oscar E Zazueta; Sila Kurugol; James C Ross; Raúl San José Estépar; Elissa Murphy; Mark P Steele; James E Loyd; Marvin I Schwarz; Tasha E Fingerlin; Ivan O Rosas; George R Washko; George T O'Connor; David A Schwartz
Journal:  N Engl J Med       Date:  2013-05-21       Impact factor: 91.245

8.  Association Between Interstitial Lung Abnormalities and All-Cause Mortality.

Authors:  Rachel K Putman; Hiroto Hatabu; Tetsuro Araki; Gunnar Gudmundsson; Wei Gao; Mizuki Nishino; Yuka Okajima; Josée Dupuis; Jeanne C Latourelle; Michael H Cho; Souheil El-Chemaly; Harvey O Coxson; Bartolome R Celli; Isis E Fernandez; Oscar E Zazueta; James C Ross; Rola Harmouche; Raúl San José Estépar; Alejandro A Diaz; Sigurdur Sigurdsson; Elías F Gudmundsson; Gudny Eiríksdottír; Thor Aspelund; Matthew J Budoff; Gregory L Kinney; John E Hokanson; Michelle C Williams; John T Murchison; William MacNee; Udo Hoffmann; Christopher J O'Donnell; Lenore J Launer; Tamara B Harrris; Vilmundur Gudnason; Edwin K Silverman; George T O'Connor; George R Washko; Ivan O Rosas; Gary M Hunninghake
Journal:  JAMA       Date:  2016-02-16       Impact factor: 56.272

9.  Lung volumes and emphysema in smokers with interstitial lung abnormalities.

Authors:  George R Washko; Gary M Hunninghake; Isis E Fernandez; Mizuki Nishino; Yuka Okajima; Tsuneo Yamashiro; James C Ross; Raúl San José Estépar; David A Lynch; John M Brehm; Katherine P Andriole; Alejandro A Diaz; Ramin Khorasani; Katherine D'Aco; Frank C Sciurba; Edwin K Silverman; Hiroto Hatabu; Ivan O Rosas
Journal:  N Engl J Med       Date:  2011-03-10       Impact factor: 91.245

  9 in total
  7 in total

1.  Impact of FDG-PET on the Detection of Patients with Lung Cancer at High Risk for ILD.

Authors:  Paul Flechsig; Olena Hural; Michael Kreuter; Martin Eichhorn; Gudula HEUßEL; Christos Sachpekidis; Hans-Ulrich Kauczor; Uwe Haberkorn; Claus Peter Heussel; Monika Eichinger
Journal:  In Vivo       Date:  2018 Nov-Dec       Impact factor: 2.155

Review 2.  Clinical Relevance and Management of "Pre-Interstitial Lung Disease".

Authors:  Anna J Podolanczuk; Rachel K Putman
Journal:  Clin Chest Med       Date:  2021-06       Impact factor: 4.967

3.  Circulating microRNA Signature Associated to Interstitial Lung Abnormalities in Respiratory Asymptomatic Subjects.

Authors:  Blanca Ortiz-Quintero; Ivette Buendía-Roldán; Eric Gustavo Ramírez-Salazar; Yalbi I Balderas-Martínez; Sandra Lizbeth Ramírez-Rodríguez; Karen Martínez-Espinosa; Moisés Selman
Journal:  Cells       Date:  2020-06-26       Impact factor: 6.600

Review 4.  Interstitial lung abnormalities: erecting fences in the path towards advanced pulmonary fibrosis.

Authors:  Gary M Hunninghake
Journal:  Thorax       Date:  2019-02-05       Impact factor: 9.139

5.  Preventing bias from selective non-response in population-based survey studies: findings from a Monte Carlo simulation study.

Authors:  Kristin Gustavson; Espen Røysamb; Ingrid Borren
Journal:  BMC Med Res Methodol       Date:  2019-06-13       Impact factor: 4.615

6.  The associations of interstitial lung abnormalities with cancer diagnoses and mortality.

Authors:  Gisli T Axelsson; Rachel K Putman; Thor Aspelund; Elias F Gudmundsson; Tomayuki Hida; Tetsuro Araki; Mizuki Nishino; Hiroto Hatabu; Vilmundur Gudnason; Gary M Hunninghake; Gunnar Gudmundsson
Journal:  Eur Respir J       Date:  2020-12-17       Impact factor: 16.671

7.  Interstitial lung abnormalities and physical function.

Authors:  Gisli Thor Axelsson; Rachel K Putman; Ezra R Miller; Tetsuro Araki; Sigurdur Sigurdsson; Elias F Gudmundsson; Gudny Eiríksdottír; Kristin Siggeirsdottir; Thor Aspelund; Lenore J Launer; Tamara B Harris; Hiroto Hatabu; Vilmundur Gudnason; Gary M Hunninghake; Gunnar Gudmundsson
Journal:  ERJ Open Res       Date:  2018-09-03
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.